Triple Assault Erases Pancreatic Tumors in Mice, Igniting Hopes for Human Trials
CNIO researchers led by Mariano Barbacid obliterated pancreatic tumors in mice using a triple-drug therapy targeting KRAS pathways, achieving permanent remission without resistance or major toxicity. Published in PNAS, results pave way for human trials against this deadly cancer.